Prometheus launches Crohn's Prognostic test
Links shared publicly online about this topic.
- 904total visits
Prometheus launches Crohn's Prognostic test
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the commercial launch of its proprietary PROMETHEUS® Crohn's Prognostic test. This novel and unique diagnostic represents a significant advance in the Prometheus Inflammatory Bowel Disease (IBD) franchise of diagnostic and prognostic tests, and complements the market-leading PROMETHEUS® IBD Serology 7.
View full resource at news-medical.net
Tags: IBD, Crohn's Disease, Disease and Condition, Pharma, Oncology, News, disease
Most Recently Shared on September 2, 2010 at 6:11 am By:
Oncology News: Prometheus launches Crohn's Prognostic test: Prometheus Laboratories Inc., a specialty pharmaceutic... http://bit.ly/a72wus
Advertisement
